Results 241 to 250 of about 288,395 (355)

Hippocampal mossy cell involvement in behavioral and neurogenic responses to chronic antidepressant treatment

, 2019
Seo-Jin Oh, Paul Greengard, Jia Cheng, Yong‐Seok Oh   +3 more
openalex   +1 more source

Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Reduced cardiac uptake on 123Iodine‐metaiodobenzylguanidine (MIBG) scintigraphy is a valuable tool for differentiating neurodegenerative parkinsonism but interpretation can be difficult due to comorbidities and drug‐tracer interactions.
Frank Jagusch, Elena Redl, Christoph Theyer, Atbin Djamshidian, Alessandra Fanciulli, Werner Poewe, Philipp Mahlknecht, Beatrice Heim, Klaus Seppi, Florian Krismer   +9 more
wiley   +1 more source

Effects of noninvasive brain stimulation in the treatment of poststroke depression: an overview of systematic reviews. [PDF]

Front Neurol
Liu S, Huang Z, Tan J, Zhao N.
europepmc   +1 more source

What is the first-line treatment, benzodiazepine and/or antidepressant, for a patient with adjustment disorder following a recent cancer diagnosis? The primary symptoms are irritability and aggression.

Tripdatabase
openalex   +1 more source

In Vivo Evaluation of the Antidepressant Activity of a Novel Polyherbal Formulation

, 2016
Rinki Kumari Verma
openalex   +1 more source

Perspective: Depression in Persons with Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17%
Albert F.G. Leentjens, Gregory M. Pontone   +1 more
wiley   +1 more source

Depression and antidepressant treatment in growing up in New Zealand: impact on preterm birth and low birth weight. [PDF]

Arch Womens Ment Health
D'Souza S, Anns F, Waldie KE, Mulder RT, Rucklidge JJ.   +4 more
europepmc   +1 more source

Comparative Study of Tricyclic and Tetracyclic Antidepressant on the Sleep-Wakefullness Cycle in Cats and the Plasma Concentrations of Antidepressant Drugs

, 1993
吉和 清田
openalex   +1 more source

Temporal Interference Stimulation Modulates Resting State Functional Connectivity of Motor Circuit in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Transcranial temporal interference stimulation (TIs) targeting the subthalamic nucleus (STN) is a novel noninvasive neuromodulation approach with potential to improve motor symptoms in Parkinson's disease (PD). However, its underlying neuroimaging mechanisms remain unclear.
Yongxin Xu, Chenhao Yang, Yichao Du, Xiaonan Shen, Tingting Li, Yufeng Zhang, Zijun Lu, Jie Zhuang, Nan Chen, Yulian Zhu, Chencheng Zhang, Jiaojiao Lü, Lingyan Huang, Lu Li, Jianqiang Lü, Zhenyu Qian, Zhen Wang, Jian Zhang, Junhong Zhou, Yu Liu   +19 more
wiley   +1 more source

The selective serotonin reuptake inhibitor sertraline causes ocular toxicity in larvae of zebrafish (<i>Danio rerio</i>). [PDF]

Front Physiol
Jafari M, Stehly Y, Pampanin DM.
europepmc   +1 more source